Intellia Therapeutics Inc buy SVB Leerink LLC
Start price
03.03.26
/
50%
€12.16
Target price
03.03.27
€24.79
Performance (%)
-3.78%
Price
07.05.26
€11.70
Summary
This prediction is currently active. With a performance of -3.78%, the BUY prediction for Intellia Therapeutics Inc by SVB_Leerink_LLC is down slightly. This prediction currently runs until 03.03.27. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 1.916% | 1.916% |
| iShares Core DAX® | 0.423% | 5.706% |
| iShares Nasdaq 100 | 4.096% | 16.639% |
| iShares Nikkei 225® | 4.469% | 18.343% |
| iShares S&P 500 | 1.788% | 9.644% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target raised by Leerink Partners from $27.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat